Characterization of the novel HLA-C*03:598 allele.

Alleles Codon Exons / genetics Genes, MHC Class I HLA-C Antigens / genetics Humans
HLA NGS bone marrow donor novel allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
09 2022
Historique:
received: 16 05 2022
accepted: 24 05 2022
pubmed: 27 5 2022
medline: 12 8 2022
entrez: 26 5 2022
Statut: ppublish

Résumé

HLA-C*03:598 differs from HLA-C*03:03:01:01 in codon 22 in exon 2.

Identifiants

DOI: 10.1111/tan.14683 PMID: 35616014
pubmed: 35616014
doi: 10.1111/tan.14683
doi:

Substances chimiques

Codon 0
HLA-C Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

277-278

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Simakova T, Suvorova A, Krivonosova K, Abramova A, Loginova M, Paramonov I. NovAT tool - reliable novel HLA alleles identification from next generation sequencing data. HLA. 2022;99(1):3-11.
Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.

Auteurs

Maria Loginova (M)

Federal State Budget Research Institution: Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.
Federal State Budget Educational Institution of Higher Professional Education: Vyatka State University, Kirov, Russia.
ORCID: 0000-0001-7088-3986

Daria Smirnova (D)

Federal State Budget Research Institution: Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.

Igor Paramonov (I)

Federal State Budget Research Institution: Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Characterization of the novel HLA-C*03:598 allele.
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Composants de gène › Codon › Characterization of the novel HLA-C*03:598 allele.
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Composants de gène › Exons › Characterization of the novel HLA-C*03:598 allele.
questionsmedicales.fr › Phénomènes du système immunitaire › Phénomènes immunogénétiques › Complexe majeur d'histocompatibilité › Gènes MHC de classe I › Characterization of the novel HLA-C*03:598 allele.
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-C › Characterization of the novel HLA-C*03:598 allele.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Characterization of the novel HLA-C*03:598 allele.